Compounds > 1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline
Page last updated: 2024-08-26

1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deleu, D1
Abe, K; Miyatake, T; Ren, J; Sano, T; Shinohara, T; Taguchi, K; Utsunomiya, I; Wasai, T1

Other Studies

2 other study(ies) available for 1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

ArticleYear
Endogenous dopamine-derived neurotoxins and Parkinson's disease.
    Acta neurologica Belgica, 1998, Volume: 98, Issue:4

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; Dopamine; Humans; Isoquinolines; Methyltransferases; MPTP Poisoning; Nerve Tissue Proteins; Neurotoxins; Parkinson Disease; Parkinson Disease, Secondary; Rats; Salsoline Alkaloids; Substantia Nigra; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase

1998
Biochemical and pathological study of endogenous 1-benzyl-1,2,3,4-tetrahydroisoquinoline-induced parkinsonism in the mouse.
    Brain research, 2001, Jul-13, Volume: 907, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Drug Administration Schedule; Homovanillic Acid; Hydroxyindoleacetic Acid; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Parkinson Disease; Parkinson Disease, Secondary; Serotonin; Substantia Nigra; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase

2001